Meeting in the golden autumn, wisdom converges in Jinling. Held from September 12 to 13, the 19th Jinling Conference on Sexual Medicine, hosted by the Chinese Society of Sexology and its Sexual Medicine Branch, and undertaken by the Chinese Andrologist Training Base (Jiangsu) and the Department of Andrology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, successfully wrapped up at Nanjing Jiangbin Hotel.

Grand Opening Ceremony

The conference kicked off with a grand opening ceremony, presided over by Professor Zhao Xiaozhi, Conference Chair and Director of the Department of Andrology, Nanjing Drum Tower Hospital. Professor Dai Yutian, Academic Leader of Andrology at Nanjing Drum Tower Hospital, Professor Zhou Min, Vice President of Nanjing Drum Tower Hospital, Professor Liu Jihong, Director of the Institute of Andrology at Tongji Hospital, Professor Liang Chaozhao from The First Affiliated Hospital of Anhui Medical University, and many other leading experts in the field delivered opening addresses successively.

The experts congratulated the convening of the conference, and encouraged all participants to further research and practice in andrology and sexual medicine, strengthen academic exchanges and clinical translation, and jointly promote high-quality innovative development of the discipline.

Special Presentation by Professor Lu Mujun

 Focus on Clinical Application of LIPUS

During the academic presentations at the main venue, Professor Lu Mujun from Renji Hospital, School of Medicine, Shanghai Jiao Tong University, delivered a keynote speech titled Application of Regenerative Medicine in Andrological Practice — Experience from Shanghai Renji Hospital, offering an in-depth interpretation of the clinical implementation of micro-energy medical technologies.

Professor Lu focused on LIPUS (Low-Intensity Pulsed Ultrasound) technology. Drawing on abundant clinical cases from Renji Hospital, he systematically explained its core mechanism of action, clinical advantages and development prospects. Supported by domestic authoritative expert consensus and substantial clinical research data, his report fully verified the efficacy and safety of WBL LIPUS in the clinical treatment of erectile dysfunction (ED).

WBL Booth Attracts Great Attention with Continuous Exchanges among Peers

WBL Medical Group is the first medical device enterprise in China featured on CCTV’s China Science & Technology Innovation. At this conference, WBL showcased its LIPUS Low-Intensity Pulsed Ultrasound ED Treatment Platform and Extracorporeal Pulsed Ultrasound Pelvic Floor Therapy Platform at the exhibition. The booth drew constant visits throughout the event, with numerous attending experts and clinical practitioners stopping by to inspect the equipment and inquire about technical details.

WBL LIPUS leverages mechanobiological effects to avoid thermal injury risks, enabling tissue repair as well as vascular and neural regeneration.

The Extracorporeal Pulsed Ultrasound Pelvic Floor Therapy Platform targets male pelvic floor disorders, repairing pelvic floor tissues via pulsed ultrasound and expanding the toolkit for non-invasive andrological treatment.

The company’s clinical and technical team was present on-site, explaining technical principles, sharing clinical cases, and conducting one-on-one communications regarding department setup and challenges in clinical implementation, creating a vibrant atmosphere for exchanges.

Academic Conclusion

Joining Forces for the Development of Men’s Health

The successful conclusion of the Jinling Conference on Sexual Medicine has built an efficient platform for academic communication within the industry and facilitated the sharing of experience on regenerative medicine and micro-energy diagnosis and treatment technologies. Moving forward, WBL Medical Group will continue to delve into micro-energy medicine for andrology, maintain close collaboration with clinical experts, support the standardized implementation of non-invasive diagnosis and treatment technologies, and contribute to the advancement of men’s health.